Mengyang Pharmaceutical Co., LTD

Latest announcement

MORE>>

Announcement on the holding of the third quarter 2022 results briefing

Announcement on the holding of the third quarter 2022 results briefing

2023-02-10

Investor contact

Board office

021-61305906
No. 369, Fengke Road, Fengxian District, Shanghai

Service hotline

0724-8886111

Address：3 Fuyao Yi Lu, Doudao District, Jingmen City, Hubei Province, China
Transmissionh：0724-8686500
Email：hbmy_monyan@163.com

ABOUT

About US Corporate culture Company honor Development course
NEWS

Company dynamics Trade news Academic exchanges
H&R

Job development Talent recruitment
PRODUCTS

Drugs in the field of tumor-re Drugs in other fields Health care products
R&D

R&d pipeline R&d progress Patient recruitment
INVESTOR

Latest announcement

COPYRIGHT© 2022 Hubei Mengyang Pharmaceutical Co., LTD. All Rights Reserved E ICP 11014915; Internet Drug Information Service Certificate No. : (E) - Non-business -2016-0032

Technical Support: SUMA